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ABSTRACT
RIG-I-like receptors (RLRs) MDA5 and RIG-I are key players in the innate antiviral response. Upon recognition of viral RNA,
they interact withMAVS, eventually inducing type I interferon production. The interferon induction pathway is commonly tar-
geted by viruses. How enteroviruses suppress interferon production is incompletely understood. MDA5 has been suggested to
undergo caspase- and proteasome-mediated degradation during poliovirus infection. Additionally, MAVS is reported to be
cleaved during infection with coxsackievirus B3 (CVB3) by the CVB3 proteinase 3Cpro, whereas MAVS cleavage by enterovirus
71 has been attributed to 2Apro. As yet, a detailed examination of the RLR pathway as a whole during any enterovirus infection is
lacking. We performed a comprehensive analysis of crucial factors of the RLR pathway, includingMDA5, RIG-I, LGP2, MAVS,
TBK1, and IRF3, during infection of CVB3, a human enterovirus B (HEV-B) species member. We show that CVB3 inhibits the
RLR pathway upstream of TBK1 activation, as demonstrated by limited phosphorylation of TBK1 and a lack of IRF3 phosphory-
lation. Furthermore, we show that MDA5, MAVS, and RIG-I all undergo proteolytic degradation in CVB3-infected cells through
a caspase- and proteasome-independent manner. We convincingly show that MDA5 andMAVS cleavages are both mediated by
CVB3 2Apro, while RIG-I is cleaved by 3Cpro. Moreover, we show that proteinases 2Apro and 3Cpro of poliovirus (HEV-C) and en-
terovirus 71 (HEV-A) exert the same functions. This study identifies a critical role of 2Apro by cleavingMDA5 andMAVS and
shows that enteroviruses use a common strategy to counteract the interferon response in infected cells.
IMPORTANCE
Human enteroviruses (HEVs) are important pathogens that cause a variety of diseases in humans, including poliomyelitis, hand,
foot, andmouth disease, viral meningitis, cardiomyopathy, andmore. Like many other viruses, enteroviruses target the host im-
mune pathways to gain replication advantage. TheMDA5/MAVS pathway is responsible for recognizing enterovirus infections
in the host cell and leads to expression of type I interferons (IFN-I), crucial antiviral signaling molecules. Here we show that
three species of HEVs all employ the viral proteinase 2A (2Apro) to proteolytically target MDA5 andMAVS, leading to an efficient
blockade upstream of IFN-I transcription. These observations suggest that MDA5/MAVS antagonization is an evolutionarily
conserved and beneficial mechanism of enteroviruses. Understanding the molecular mechanisms of enterovirus immune eva-
sion strategies will help to develop countermeasures to control infections with these viruses in the future.
Type I interferons (IFNs; alpha/beta interferon [IFN-/]) arekey players in the innate antiviral response against virus infec-
tions. Initially produced and secreted by infected cells, IFN-/
can bind to the type I IFN receptor (IFNAR) in autocrine and
paracrine manners, thereby initiating the JAK/STAT pathway. Ac-
tivation of this pathway leads to the expression of hundreds of
interferon-stimulated genes (ISGs), which together induce a so-
called antiviral state that restricts virus replication (reviewed in
reference 1). The initiation of the IFN-/ response relies on spe-
cialized pathogen recognition receptors (PRRs) that recognize
pathogen-associated molecular patterns (PAMPs), molecular
motifs bearing non-self-signatures to the host cell. Some members
of the Toll-like receptor (TLR) family, such as TLR3 and TLR7/8,
are known to play crucial roles in virus recognition. TLRs are
mostly expressed in macrophages, dendritic cells, and other im-
mune cell types, where they detect PAMPs at the cell surface or in
endosomes (2). Another family of PRRs is the RIG-I-like recep-
tors, including RIG-I (3), MDA5 (4–6), and LGP2 (3, 7). These
receptors are ubiquitously expressed and monitor the cytoplasm
of virtually all nucleated cells. Upon activation by viral RNA,
RIG-I and MDA5 interact with MAVS, an adaptor molecule lo-
calized at the outer membrane of mitochondria (8–11). MAVS
then initiates signaling cascades via TANK-binding kinase 1
(TBK1) and IB kinase (IKK) complexes, leading to activation of
IRF3 and NF-B, transcription factors required for transcription
activation of IFN-/ and other proinflammatory cytokine genes
(2). RIG-I and MDA5 have nonredundant roles in detecting in-
vading viruses. While RIG-I is crucial in detecting many negative-
strand RNA viruses (e.g., vesicular stomatitis virus and influenza
virus) and some flaviviruses (e.g., hepatitis C virus and Japanese
encephalitis virus) (12–15), MDA5 is important for the recogni-
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tion of members of the Picornavirus, Coronavirus, and Calicivirus
families (16–18). The molecular motifs that activate RIG-I and
MDA5 also vary. RIG-I is activated by 5=-triphosphate (5=ppp)-
containing double-stranded RNAs (dsRNAs) as well as double-
stranded regions within single-stranded RNA molecules, such as
the panhandle structure formed by genomic RNAs of negative-
strand RNA viruses (2, 19, 20). MDA5 requires long dsRNA du-
plexes for potent activation, as exemplified by the replicative form
of picornaviruses (16, 21).
The Picornaviridae is a large family of nonenveloped, positive-
strand RNA viruses. This family includes many important human
and animal pathogens, and members of the Enterovirus genus are
particularly important. Poliovirus (PV), the causative agent of po-
liomyelitis, is the subject of a multi-billion-dollar eradication
campaign from the World Health Organization. Enterovirus 71
(EV71) continues to cause outbreaks of hand, foot, and mouth
disease associated with neurological complications in Southeast
Asia. Coxsackieviruses (CVs) and echoviruses are the leading
causes of viral meningitis and cardiomyopathy. Rhinoviruses
cause common colds and are frequently associated with asthma
exacerbations and chronic obstructive pulmonary disease. Upon
entry, the viral genome is immediately translated into a single
polyprotein, which is proteolytically processed into mature pep-
tides by viral proteinases 2Apro and 3Cpro. These viral proteins
then facilitate viral RNA replication and, eventually, production
of progeny virion particles. Like most viruses, picornaviruses have
evolved to actively suppress the host IFN-/ response to gain a
replication advantage. In fact, many reports have demonstrated
that picornaviruses efficiently suppress IFN-/ at the transcrip-
tion level in cultured cells (16, 22, 23). However, the mechanism
by which picornaviruses interfere with IFN-/ induction is not
completely understood.
Many studies have been performed to investigate how picor-
naviruses interfere with the RIG-I like receptor (RLR)-mediated
IFN-/ induction pathway. MDA5, the receptor responsible for
recognizing picornavirus RNA, is reported to be degraded during
infection of PV (24) and EV71 (25). MDA5 degradation was
shown to be dependent on caspases and, in the case of PV, also
proteasome activities (24). Surprisingly, other closely related en-
teroviruses, such as human rhinovirus 16 (HRV16) and echovirus
1, did not induce MDA5 degradation (24), suggesting that there
may be variations among enteroviruses in their strategies to sup-
press IFN-/ induction. Besides MDA5, RIG-I is also targeted by
several enteroviruses, such as PV, echovirus, and HRV16 and -1A,
most likely via their 3Cpros (26), though it remains to be elucidated
why these viruses would target an RNA sensor that does not par-
ticipate in their recognition. In addition, the downstream adaptor
molecule MAVS is targeted by several enteroviruses, including
HRV1A (27), coxsackievirus B3 (CVB3) (23), and EV71 (28).
However, different mechanisms regarding how these viruses ac-
complish MAVS inactivation have been proposed. MAVS is re-
ported to be cleaved by 2Apro during EV71 infection (28) and by
3Cpro during CVB3 infection (23), whereas both of these viral
proteinases, as well as caspase 3, were implicated in HRV1A-in-
duced MAVS cleavage (27). This diversity in MAVS inactivation
mechanisms is rather uncommon for enteroviruses, as they often
utilize the same strategies to target a particular host factor. For
instance, eukaryotic initiation factor 4G (eIF4G) is cleaved by the
2Apros of various enteroviruses and rhinoviruses (29, 30), while
G3BP is cleaved by the 3Cpro of PV (31) as well as by that of CVB3
(this study). Importantly, each of the studies focused on a single
factor (MDA5, MAVS, or RIG-I) and used a different group of
viruses. Hence, it is yet impossible to paint a complete picture of
the IFN-/ antagonization strategy of any individual virus, and it
is challenging to conclude with confidence whether different en-
teroviruses truly employ diverse strategies to inactivate these host
factors or whether the differences merely result from the use of
different reagents and/or assays in different studies.
To gain a comprehensive overview of the fate of the important
components of the RLR signaling pathway during enterovirus in-
fection, we examined multiple factors along the signaling cascade
during infection of a model virus, CVB3. We show that RIG-I is
targeted by 3Cpro of CVB3, PV, and EV71, resulting in similar
cleavage products previously reported for PV (26). Importantly,
we report that cleavage of MDA5 occurs in a caspase- and protea-
some-independent manner and relies on viral proteinase 2Apro.
Furthermore, in contrast to a previous report (23), we demon-
strate that MAVS cleavage during CVB3 infection is also (primar-
ily) mediated by 2Apro and not 3Cpro. Moreover, we show that
2Apros from other enteroviruses, namely, PV and EV71, also target
MDA5 and MAVS for cleavage, suggesting that enteroviruses
likely share common strategies to target the RLR-mediated IFN-
/ induction pathway.
MATERIALS AND METHODS
Cells and viruses. HeLa R19 cells were maintained in Dulbecco modified
Eagle medium supplemented with 10% fetal calf serum and 100 U/ml
penicillin-streptomycin in a humidified incubator in the presence of 5%
CO2. Coxsackievirus B3, mengovirus, and a mengovirus which lost its
IFN-suppressing activities due to substitutions in the Zn finger domain of
the leader protein (mengo-Zn) have been described previously (16).
M-2A(CVB3/PV/EV71) and M-3C(CVB3/PV/EV71) cDNAs were gener-
ated by cloning the 2Apro- or 3Cpro-coding region of the indicated viruses,
respectively, upstream of the leader-coding region in the mengovirus in-
fectious clone pM16.1. To ensure proper maturation of the 2Apro or 3Cpro
from the mengovirus polyprotein, we also added glutamine-glycine
codons after the inserted sequences, to allow cleavage by mengovirus
3Cpro during polyprotein processing. Viruses were produced by directly
transfecting in vitro-transcribed RNAs from the infectious clones of
M-2A(CVB3/PV/EV71) and M-3C(CVB3/PV/EV71) in BHK-21 or HeLa
R19 cells.
Plasmids. pcDNA3-FLAG-MAVS-HA was generated by inserting the
hemagglutinin (HA) tag in pcDNA3-FLAG-MAVS, provided by Z. Chen
(University of Texas Southwestern Medical Center, Texas). The Q148A
mutation was generated by site-directed mutagenesis.
Reagents. Antibodies against MDA5 have been previously described
(32). Antibodies against RIG-I were purchased from Abgent, MAVS was
purchased from Alexis-Biochemicals, IRF3 was purchased from Santa
Cruz Biotechnology, p-IRF3 (S396), TBK1, and phosphorylated TBK1
(p-TBK1; phosphorylation at S172) were purchased from Cell Signaling
Technology, LGP2 was purchased from Abcam, actin and the FLAG tag
were purchased from Sigma-Aldrich, eIF4G was purchased from Bethyl
Laboratories, the HA tag was purchased from Covance, G3BP was pur-
chased from BD Biosciences, and procyclic acidic repetitive protein
(PARP) was purchased from Roche Applied Sciences. Q-VD-OPh (QVD)
was purchased from BioVision, MG132 was purchased from Sigma-Al-
drich, and staurosporine (STS) was purchased from Roche Applied Sci-
ences. Recombinant CVB3 2Apro has been previously described (33), and
recombinant CVB3 3Cpro was a kind gift from Rolf Hilgenfeld (University
of Lübeck, Lübeck, Germany).
Quantitative real-time PCR was performed as previously described
(16).
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Immunoblotting. Cells were lysed in TEN lysis buffer (40 mM Tris-
HCl, 150 mM NaCl, 10 mM EDTA, 1% NP-40), and lysate was cleared by
centrifugation at 16,000 g at 4°C for 5 min. Total protein concentrations
were determined using Bio-Rad protein assay dye reagent concentrate
according to the manufacturer’s protocols. Lysates were subjected to SDS-
PAGE and immunoblotting using the indicated antibodies. Native PAGE
(for IRF3 dimerization assay) was performed as described previously (22).
In vitro cleavage with recombinant 2Apro or 3Cpro. Cells were resus-
pended in a 2 volume of the cell pellet of hypotonic buffer [20 mM
HEPES, pH 7.4, 10 mM KCl, 1.5 mM Mg(CH3COO)2, 1 mM dithiothre-
itol (DTT)], incubated on ice for 10 min, and lysed by repeated passage
through a thin needle at 4°C. A 0.1 volume of buffer A [200 mM HEPES,
pH 7.4, 1.2 M KCH3COO, 40 mM Mg(CH3COO)2, 50 mM DTT] was
added to the cell lysate, and this was cleared by centrifugation at 2,500
g for 5 min at 4°C. Unless indicated otherwise, 0.5 g 2Apro or 0.75 g
3Cpro was incubated with 150 g lysate at room temperature overnight.
The reaction was terminated by addition of Laemmli sample buffer and
heat treatment at 95°C for 10 min.
RESULTS
CVB3 interrupts the RLR pathway upstream of TBK1 phos-
phorylation. It is known that picornaviruses induce little IFN-/
response in infected cells (23, 28, 34). In cells infected with wild-
type (wt) CVB3 or mengovirus (a strain of encephalomyocarditis
virus [EMCV] that was used as a control), little IFN-mRNA was
detected, and only at very late stages of infection (i.e., at 9 and 12
h postinfection [p.i.]) (Fig. 1A). In contrast, infection with a mu-
tant mengovirus which lost its IFN-suppressing activities due to
substitutions in the Zn finger domain of the leader protein
(mengo-Zn) (22) already induced strong IFN- mRNA upregu-
lation at 6 h p.i., and this further dramatically increased and even-
tually reached a plateau at 9 h p.i. (Fig. 1A). This increased IFN-
/ response induced by mengo-Zn was not due to differences in
virus replication, as viral RNA accumulated with kinetics and at
levels similar to those for wt mengovirus and CVB3 (Fig. 1B).
To gain a first insight into how the viruses interfere with IFN-
/ induction pathways, we first asked whether the key transcrip-
tion factor required for IFN-/ transcription activation, namely,
IRF3, is activated in infected cells. HeLa R19 cells were infected
with CVB3 and harvested at 6, 9, and 12 h p.i. Cell lysates were
subjected to immunoblotting to determine the IRF3 expression
level, as well as the activation status of IRF3, as indicated by phos-
phorylation at serine 396 and dimerization of this transcription
factor. We also performed parallel experiments with mengovirus
or mengo-Zn as negative and positive controls, respectively. In-
fection with mengo-Zn, but not wt mengovirus, induced efficient
IRF3 phosphorylation and dimerization (Fig. 1C). CVB3 infec-
tion did not induce any detectable IRF3 phosphorylation or
dimerization (Fig. 1C), consistent with the lack of a significant
IFN-mRNA induction (Fig. 1A). The absence of IRF3 activation
was not due to changes in IRF3 expression levels, since these
remained unchanged throughout the CVB3 (and mengovirus)
infection (Fig. 1C). Our data clearly indicate that the IFN-/
induction pathway is severely inhibited upstream of IRF3
phosphorylation during wt CVB3 infection.
It is well established that IRF3 phosphorylation relies on the
FIG 1 CVB3 antagonizes the RLR pathway upstream of TBK1, while mengovirus does so downstream of TBK1 activation. HeLa R19 cells were mock infected
or infected with CVB3, mengovirus (mengo), or mengo-Zn (M-Zn) at a multiplicity of infection of 50, and cells were harvested at the indicated times (h) p.i. Total
RNA was isolated and subjected to reverse transcription-quantitative PCR analysis for IFN-mRNA (A) and viral RNA (vRNA) (B). Data were first normalized
against those for actin mRNA, and then the fold induction compared to that for the mock-infected sample was calculated and is presented as the mean SD. (C)
Infection was carried out as described for panel A, and cells were lysed at the indicated times (h) p.i. Lysates were then subjected to SDS-PAGE, followed by
immunoblotting using the indicated antibodies. IRF3 dimerization analysis was carried out under native conditions. Lane M, mock infection. (D) Infection was
carried out as described for panel A, and cells were lysed at 9 h p.i. Cell lysates were analyzed by SDS-PAGE, followed by immunoblotting using the indicated
antibodies. Data are representative of those from at least 3 independent experiments.
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activity of TBK1, which is itself activated by phosphorylation at
serine 172 (35). We therefore asked whether TBK1 expression
and/or activation is affected in CVB3-infected cells. Cells were
infected with CVB3, wt mengovirus, and mengo-Zn for 9 h, and
cell lysates were analyzed by immunoblotting using a polyclonal
antibody against TBK1 and a monoclonal antibody against S172-
phosphorylated TBK1. As shown in Fig. 1D, the basal level of
TBK1 expression did not change during infection with any of the
three viruses. As expected, S172 phosphorylation of TBK1 was
readily detectable in mengo-Zn-infected cells. wt mengovirus in-
fection also resulted in TBK1 phosphorylation to the same extent
as mengo-Zn infection, but this was significantly reduced in
CVB3-infected cells (Fig. 1D). These results indicate that CVB3
targets the RLR pathway upstream of TBK1 phosphorylation,
while mengovirus does so between TBK1 activation and IRF3
phosphorylation.
CVB3 inducesMDA5,MAVS, and RIG-I cleavage in infected
cells. To further investigate where CVB3 interferes with the RLR
pathway, we examined the crucial factors involved in this signal-
ing cascade by immunoblotting during a course of infection.
From 9 h p.i. onwards, we observed a decrease in the full-length
MDA5 signal accompanied by the appearance of a smaller product
of about 100 kDa (Fig. 2), suggesting that MDA5 is cleaved during
CVB3 infection. Also, RIG-I and MAVS, but not TBK1 or LGP2,
another member of the RLR family, were cleaved from 9 h p.i. (Fig.
2). RIG-I cleavage was accompanied by the appearance of a band
at about 70 kDa, similar to the cleavage product observed in PV-
infected cells (26). We also observed a putative cleavage product
(37 kDa) of MAVS (Fig. 2) which was significantly smaller than
the reported cleavage product (	50 kDa) produced by CVB3
3Cpro (23), suggesting an alternative MAVS cleavage. None of
these factors were cleaved during infection of mengovirus or
mengo-Zn (Fig. 2), in agreement with our observation that the
RLR pathway upstream of TBK1 phosphorylation remains intact
in cells infected with these viruses (Fig. 1).
CVB3-inducedMDA5,MAVS, and RIG-I cleavages are inde-
pendent of caspase or proteasome activities. We noticed that the
cleavage of RIG-I, MDA5, and MAVS in CVB3-infected cells co-
incided with PARP cleavage, resulting in an 89-kDa cleavage
product (Fig. 2), the hallmark of apoptosis. It has been sug-
gested that poliovirus and enterovirus 71 induce caspase-de-
pendent MDA5 degradation (24, 25). Therefore, we asked
whether caspases could be responsible for cleaving MDA5, MAVS,
and/or RIG-I in CVB3-infected cells. To address this question, we
chemically induced apoptosis in mock-infected cells using stauro-
sporine (STS), a general kinase inhibitor. MDA5, MAVS, and
RIG-I in mock- or STS-treated cells were analyzed by immuno-
blotting. STS induced potent caspase activation, as shown by
PARP cleavage, as well as the appearance of the known caspase
3-mediated MAVS cleavage product of about 50 kDa (27). How-
ever, it did not lead to any detectable cleavage of MDA5, MAVS, or
RIG-I like that observed in CVB3-infected cells (Fig. 3A), suggest-
ing that caspases or the proteasome may not catalyze the infec-
tion-induced cleavage events reported here. To further demon-
strate that MDA5 is not cleaved by caspases, we infected cells with
CVB3 in the presence of a broad-spectrum caspase inhibitor, Q-
VD-OPh (QVD). We also included a proteasome inhibitor,
MG132, in a parallel experiment because efficient caspase activa-
tion like the one that we observed in CVB3-infected cells (Fig. 2)
often leads to protein degradation via the proteasome system.
QVD and MG132 both inhibited apoptosis, as demonstrated by
significantly decreased PARP cleavage in treated cells (Fig. 3A).
Under these conditions, CVB3 infection still induced MDA5,
MAVS, and RIG-I cleavage to an extent similar to that in non-
treated cells (Fig. 3A). Also, in an independent experiment where
apoptosis was completely inhibited by QVD, efficient MDA5
cleavage induced by CVB3 infection was observed (Fig. 3B). To-
gether with our STS data, these results indicate that the cleavage
events of MDA5, MAVS, and RIG-I during CVB3 infection are not
mediated by caspases or the proteasome.
Recombinant CVB3 proteinase 2Apro induces MDA5 and
MAVS cleavage, and 3Cpro induces RIG-I cleavage. Next, we
asked whether the two viral proteinases 2Apro and 3Cpro could be
responsible for the cleavage events that we observed during CVB3
infection. Since these proteinases efficiently shut off host mRNA
translation by cleaving eIF4G (29, 36, 37), their overexpression
results in poor expression levels and severe cytotoxicity. There-
fore, we chose to address this question using recombinant 2Apro
and 3Cpro. Native cell lysate was treated with recombinant 2Apro or
3Cpro and subjected to immunoblotting analysis using antibodies
against MDA5, MAVS, and RIG-I. To control for the activities of
2Apro and 3Cpro, we also probed for eIF4G, which is known to be
cleaved by 2Apro- and 3Cpro-activated caspase 3 (29, 37, 38), and
G3BP, which is cleaved by 3Cpro only (31). As clearly shown in Fig.
4, both proteinases were very active in our in vitro cleavage assay.
Under these conditions, MDA5 and MAVS cleavages were ob-
served in 2Apro-treated samples, whereas RIG-I was cleaved in
FIG 2 Fate of multiple factors of the RLR signaling pathway during infection.
HeLa R19 cells were mock infected or infected with CVB3, mengovirus
(mengo), or mengo-Zn (M-Zn) at a multiplicity of infection of 50, and cells
were lysed at the indicated times (h) p.i. Cell lysates were analyzed by SDS-
PAGE, followed by immunoblotting using the indicated antibodies. Marker
bands of the indicated size (in kDa) are indicated on the right side. Arrow with
a narrow tail, full-length protein; arrowhead, putative cleavage products; ar-
row with a wide tail, known MAVS cleavage product from caspase-mediated
cleavage. Data are representative of those from at least 3 independent experi-
ments.
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3Cpro-treated lysate (Fig. 4). The cleavage products seen in the in
vitro cleavage assay showed electrophoretic mobility identical to
the mobility of the cleavage products from CVB3-infected cells
(Fig. 4), demonstrating the relevance of our in vitro findings. In
3Cpro-treated samples, a putative MDA5 cleavage product of ap-
proximately 100 kDa was detected; however, this protein frag-
ment was not consistently detected in in vitro cleavage assays with
3Cpro. More importantly, we never observed this cleavage product
in CVB3-infected cells. These results suggest that the CVB3-in-
duced cleavage of MDA5 and MAVS resulted from 2Apro activity,
whereas that of RIG-I resulted from 3Cpro activity.
As mentioned before, it has been reported that CVB3 3Cpro
cleaves MAVS, resulting in an N-terminal cleavage product of 50
kDa, and a single amino acid substitution at position 148 (Q148A)
was sufficient to prevent this cleavage (23). We also observed a
3Cpro-induced cleavage product of approximately 50 kDa when
we prepared lysates from cells overexpressing a FLAG- and HA-
tagged MAVS protein (FLAG-MAVS-HA) (Fig. 5A). This cleavage
product was also detectable using an antibody against the N-ter-
minal FLAG tag but not one against the C-terminal HA tag, con-
firming that it is an N-terminal fragment of MAVS. When the
reported cleavage-resistant mutant (Q148A) was overexpressed,
the 3Cpro-mediated cleavage was no longer detectable (Fig. 5B),
indicating that it is likely the same cleavage product reported by
Mukherjee et al. (23). However, we did not observe this cleavage
fragment from endogenous MAVS during CVB3 infection (Fig. 2
to 4), even when using the same antibody used in the previously
published study (23) (data not shown).
The 2Apro-mediated cleavage was readily detectable from both
overexpressed MAVS (Fig. 5) and endogenous MAVS (Fig. 2 to 4),
releasing two cleavage products (approximately 30 and 40 kDa)
FIG 3 Caspases and proteasomal proteases are not responsible for CVB3-induced MDA5, MAVS, or RIG-I cleavage. (A) HeLa R19 cells were mock infected,
infected with CVB3 at a multiplicity of infection of 50 for 9 h, or treated with 2 M staurosporine (STS) for 6 h in the presence or absence of 10 M QVD or 10
M MG132. Cells were lysed, and the indicated proteins were analyzed by SDS-PAGE, followed by immunoblotting. Arrow with a narrow tail, full-length
protein; arrowhead, putative cleavage products; arrow with a wide tail, known MAVS cleavage product from caspase-mediated cleavage. Marker bands of the
indicated size (in kDa) are indicated on the right side. (B) HeLa R19 cells were mock treated, infected with CVB3 at a multiplicity of infection of 50 for 9 h, or
treated with 2 M STS for 6 h in the presence or absence of 10 M QVD or 10 M MG132. Cells were lysed, and MDA5, PARP, and actin were analyzed by
SDS-PAGE, followed by immunoblotting. Arrow with a narrow tail, full-length protein; arrowhead, putative cleavage products; arrow with a wide tail, additional
PARP-derived fragment that was observed in CVB3-infected but not STS-treated cells and that persisted throughout CVB3 infection. Data are representative of
those from at least 5 experiments.
FIG 4 Recombinant CVB3 2Apro cleaves MDA5 and MAVS, while 3Cpro
cleaves RIG-I. A native lysate of HeLa R19 cells was treated with recombinant
CVB3 2Apro or 3Cpro at room temperature overnight. The reaction mixtures
were subjected to SDS-PAGE, followed by immunoblotting using antibodies
against the indicated proteins. As controls, lysates from mock- and CVB3-
infected (multiplicity of infection, 50; 8 h) cells were also included. Arrow,
full-length protein; arrowhead, putative cleavage products; filled diamond,
product obtained by cleavage of MDA5 by 3Cpro that is not seen in CVB3-
infected cells. Marker bands of the indicated size (in kDa) are indicated on the
right side. Data are representative of those from at least 3 experiments.
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(Fig. 5). Using antibodies against tags at either terminus of over-
expressed MAVS, we saw that the smaller cleavage product repre-
sented an N-terminal fragment, whereas the larger product was a
C-terminal fragment (Fig. 5). These data suggest that MAVS is
primarily cleaved by 2Apro in CVB3-infected cells.
2Apro mediates cleavage of MDA5 and MAVS, while 3Cpro
cleaves RIG-I in infected cells. We further pursued experiments
to confirm these results in the context of an infection. As 2Apro and
3Cpro are both essential for CVB3 polyprotein processing, deletion
mutations of these proteinases are lethal. Instead, we took advan-
tage of the fact that wt mengovirus does not induce cleavage of
RIG-I, MDA5, or MAVS (Fig. 2). By inserting CVB3 2Apro or
3Cpro in front of the leader-coding region (i.e., at the extreme 5=
terminus of the polyprotein-coding region) in the mengovirus
genome, we could study the role of the CVB3 proteinases in the
cleavage events during a normal picornavirus infection. These vi-
ruses, named M-2A(CVB3) and M-3C(CVB3), were used to infect
cells, and RIG-I, MDA5, and MAVS cleavages were examined
by immunoblotting. As shown before, wt mengovirus infection
did not induce any changes in the integrity of these factors,
whereas M-2A(CVB3) induced MDA5 and MAVS cleavage, and
M-3C(CVB3) induced RIG-I cleavage (Fig. 6A). The cleavage
products observed in M-2A(CVB3)- and M-3C(CVB3)-infected
cells were exactly the same as those seen in CVB3-infected cells
(Fig. 6A). We observed an additional band at about 90 kDa with
the anti-RIG-I antibody in M-2A(CVB3)-infected cells (Fig. 6A).
We never observed a cleavage product of this electrophoretic mo-
bility in wt CVB3-infected cells, and this 90-kDa band was also
absent in M-2A(CVB3)-infected cells in other experiments (Fig.
6B). As additional controls to confirm that the cleavages were the
result of the proteinase activities of 2Apro and 3Cpro, we also pro-
duced mutant mengoviruses carrying the catalytically inactive
FIG 5 Both 2Apro and 3Cpro of CVB3 can cleave MAVS, but at different
sites. Plasmids carrying FLAG-MAVS-HA (A) or FLAG-MAVS-HA
(Q148A) (B) were transfected into cells and lysed 24 h later under native
conditions. The native lysates were treated with recombinant 2Apro or
3Cpro at room temperature overnight and analyzed by SDS-PAGE and
immunoblotting using the indicated antibodies. Arrow, full-length pro-
tein; arrowhead, putative cleavage product. Marker bands of the indicated
size (in kDa) are indicated on the right side of each panel. Data are repre-
sentative of those from at least 2 experiments.
FIG 6 MDA5, MAVS, and RIG-I cleavage in the context of an infection. (A) HeLa R19 cells were mock infected or infected with CVB3, mengovirus expressing
CVB3 2Apro or 3Cpro (M-2A and M-3C, respectively), or wt mengovirus at a multiplicity of infection of 50 for 8 h. Cells were lysed, and the indicated proteins were
analyzed by SDS-PAGE, followed by immunoblotting. Arrow, full-length protein; arrowhead, putative cleavage products; filled diamond, product obtained by
cleavage RIG-I by 2Apro that is not seen in CVB3-infected cells. (B) HeLa R19 cells were mock infected or infected with CVB3, M-2A(CVB3), M-3C(CVB3),
M-2A-C109A(CVB3), or M-3C-C147A(CVB3) at a multiplicity of infection of 50 for 8 h. Cells were lysed, and the indicated proteins were analyzed by SDS-PAGE
followed by immunoblotting. Arrow, full-length protein; arrowhead, putative cleavage products. Marker bands of the indicated size (in kDa) are indicated on the
right side of each panel. Data are representative of those from at least 3 experiments.
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forms of 2Apro (2A-C109A) and 3Cpro (3C-C147A). Infection with
these viruses did not lead to cleavage of targets of 2Apro or 3Cpro
(Fig. 6B). These results, combined with our in vitro cleavage data,
convincingly show that CVB3 induces MDA5 and MAVS cleavage
via 2Apro activity and RIG-I cleavage via 3Cpro activity.
Other enteroviruses also target MDA5 and MAVS by their
2Apros and RIG-I by their 3Cpros. We further asked whether the
cleavage events that we observed here were unique to CVB3, a
human enterovirus B (HEV-B) member, or are common to other
enterovirus species as well. To this end, we produced mengovi-
ruses carrying 2Apro or 3Cpro from enterovirus 71 (EV71) and
poliovirus (PV), belonging to HEV-A and HEV-C, respectively.
Infections with these mutant viruses revealed that the 2Apro and
3Cpros from both viruses induced MDA5 and RIG-I cleavage,
respectively (Fig. 7A). The cleavage products found with these
viruses were identical to the corresponding cleavage products
observed in CVB3-infected cells (Fig. 6A). M-2A(EV71) and
M-2A(PV) infections also induced MAVS cleavage, though
M-2A(PV) infection resulted in a less prominent MAVS cleavage
and a MAVS cleavage product pattern slightly different from
that of CVB3 infection. The larger cleavage product (	40 kDa)
seemed to be identical to that from M-2A(CVB3)- and
M-2A(EV71)-infected cells, but the smaller product (	35 kDa)
had a slower electrophoretic mobility than that from CVB3-in-
fected cells (	30 kDa) (Fig. 7A).
To investigate whether these cleavages also occur during a nor-
mal infection of enteroviruses, we infected cells with EV71 (strain
BrCr) and analyzed MDA5, MAVS, and RIG-I by immunoblot-
ting. Infection with EV71 induced the cleavage of all three factors
similar to that seen in CVB3-infected cells (Fig. 7B). Together with
data from the M-2A viruses, our results suggest that cleavage of
RIG-I, MDA5, and MAVS may be a common phenomenon
among enteroviruses.
DISCUSSION
The RLR signaling pathway is a crucial part of the innate antiviral
response. Consequently, this pathway is targeted by numerous
viruses from various families, including picornaviruses. However,
our knowledge on how picornaviruses interfere with this pathway
remains somewhat fragmented, since the reported studies each
used a different panel of viruses and focused on only one factor of
the pathway at a time. Here we performed the first comprehensive
analysis of key factors of the RLR signaling pathway during en-
terovirus infections. Our data suggest that enteroviruses utilize
their 2Apros to target MDA5 and MAVS and their 3Cpros to cleave
RIG-I.
Consistent with these results, several studies have reported that
IRF3 activation is severely inhibited during enterovirus infection
(Fig. 1C) (23, 25, 27). Thus, cleavage of upstream factors of the
RLR pathway is likely an evolutionarily conserved and advanta-
geous mechanism to suppress IFN type I gene transcription.
Meanwhile, it is worth noting that RLR pathway antagonization
may not be the only evasion mechanism of enteroviruses. It is
known that enteroviruses induce a shutoff of host mRNA tran-
scription and translation, which likely further limits the produc-
tion of, among other factors, virus-induced cytokines, such as
IFNs. To what extent the host shutoff contributes to suppressing
IFN production is difficult to investigate, since enterovirus-in-
duced host shutoff is also mediated by 2Apro and 3Cpro (38–40),
the same proteinases that cleave factors of the RLR-mediated IFN
induction pathway, making it difficult to separately investigate the
role of these phenomena.
MDA5, the receptor responsible for sensing picornavirus in-
fection (16, 21), is cleaved during infection of CVB3 and EV71.
Using recombinant CVB3 2Apro and our M-2A viruses carrying
2Apro of CVB3, EV71, or PV, we demonstrate that this cleavage
can be mediated by all these 2Apros, indicating that this may be a
common strategy by which enteroviruses inactivate MDA5. This
seems to contradict previous reports that PV and EV71 induce
caspase-mediated (and, in the case of PV, also proteasome-medi-
ated) MDA5 degradation. However, in those studies, cells were
first transfected with either poly(I·C) (24) or viral RNA (25) in
order to upregulate MDA5 expression to a detectable level before
infections were carried out. Pretreatments with these triggers in-
duce IFN-/ production, which, in turn, upregulates expression
of interferon-stimulated genes, including MDA5. It is important
to realize that IFN-/ itself is known to potentiate cells to virus-
induced apoptosis (41). Therefore, it is likely that in IFN-/-
FIG 7 MDA5, MAVS, and RIG-I cleavage by other enteroviruses. (A) HeLa R19 cells were mock infected or infected with CVB3, M-2A(CVB3), M-2A(EV71),
M-2A(PV), M-3C(CVB3), M-3C(EV71), or M-3C(PV) at a multiplicity of infection of 50 for 8 h. Cell lysates were analyzed by SDS-PAGE, followed by
immunoblotting using antibodies against the indicated proteins. (B) HeLa R19 cells were mock infected or infected with CVB3 or EV71 at a multiplicity of
infection of 50 for 8 h. Cells lysates were analyzed as described for panel A. Arrow, full-length protein; arrowhead, putative cleavage product. Marker bands of the
indicated size (in kDa) are indicated on the right side of each panel. Data are representative of those from at least 2 experiments.
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primed virus-infected cells, MDA5 is degraded in a caspase-de-
pendent manner. In this study, we investigated the fate of
endogenous MDA5 during enterovirus infection of naive cells. We
show convincingly that MDA5 cleavage during infection is not
attributed to caspases or the proteasome but is attributed to the
viral proteinase 2Apro.
We also set out to identify the 2Apro cleavage site in MDA5 by
infecting cells overexpressing MDA5 mutants carrying substitu-
tions at potential 2Apro recognition sites. However, infection fol-
lowing protein overexpression proved to be very inefficient in our
hands (i.e., viruses preferably infect nontransfected cells) (data
not shown). Another approach to test potential cleavage-resistant
MDA5 mutants was to use lysates from cells overexpressing tagged
MDA5 mutants in our in vitro cleavage assay. However, under
conditions where we did observe cleavage of endogenous MDA5
or MAVS or overexpressed MAVS (e.g., in the Q148A mutant), we
did not find any cleavage product of the overexpressed MDA5 (as
detected by antibodies against terminal epitope tags) (data not
shown). In addition, no cleavage of recombinant MDA5 purified
from mammalian cells was observed (data not shown). It eludes us
why overexpressed MDA5 was so poorly cleaved by recombinant
2Apro, and unfortunately, it did not allow us to further investigate
and identify the 2Apro cleavage site in MDA5.
In addition to MDA5, the downstream adaptor molecule
MAVS was also cleaved in a 2Apro-dependent manner during en-
terovirus infection. CVB3 and EV71 induced identical MAVS
cleavage products. These products were also reasonably similar to
what was previously observed when in vitro-translated MAVS was
treated with CVB3 2Apro (27), further supporting our conclusion
that this is a 2Apro-mediated cleavage. PV 2Apro also led to MAVS
cleavage, suggesting a similar cleavage mechanism, though the
cleavage products were slightly different from those induced by
CVB3. While this paper was in preparation, it was shown in an-
other study that EV71 2Apro cleaves MAVS at three distinct posi-
tions, namely, Q209, Q251, and Q265, leading to the production
of two cleavage products of 30 to 40 kDa (28). We show here that
both CVB3 and EV71 induce identical MAVS cleavage patterns,
yielding two cleavage products similar in size to those reported in
that study, leading us to conclude that CVB3 2Apro likely also
cleaves MAVS at these positions. Furthermore, 2Apro of PV also
targeted MAVS, though the size of one of the cleavage products
was slightly different from that observed in CVB3- or EV71-in-
fected cells. It is not at odds with the finding that 2Apros from
different enteroviruses cleave the same target protein at various
positions. It has previously been shown that 2Apros of human rhi-
noviruses cleave nucleoporins at different sites, most likely due to
sequence diversity in 2Apro (42). Moreover, caspase-mediated
MAVS cleavage has been suggested for HRV1A (27). We did not
observe the caspase-mediate MAVS cleavage product during
CVB3 infection in HeLa R19 cells or cells of other human cell lines,
such as HeLa Kyoto and Huh7 (data not shown). Together, our
data show that the 2Apros from three different enterovirus species
all target not only MDA5 but also MAVS during infection. The
evolutionary conservation of these activities suggests that this is
probably highly advantageous for enterovirus replication.
Although RIG-I is dispensable in sensing picornaviruses (16),
it has been reported to be cleaved during infection of a few entero-
viruses, such as PV, echovirus, and HRV16, mostly likely via their
3Cpros. Here we provide data that two additional enteroviruses,
namely, CVB3 and EV71, also cleave RIG-I via their 3Cpros. Unlike
the various 2Apro cleavage sites in MAVS, the yet unidentified site
in RIG-I cleaved by 3Cpro seems to be well conserved across this
panel of different enteroviruses, each yielding a putative cleavage
product of approximately 70 kDa (26).
Cleavage of RIG-I, MDA5, and MAVS does not appear to be
common to all picornaviruses. In this study, we also examined the
fate of factors involved in the RLR pathway during infection with
mengovirus, a species of EMCV of the Cardiovirus genus. We
show that MDA5, MAVS, RIG-I, LGP2, and TBK1 all remained
intact in cells infected with either wt mengovirus, which effectively
suppresses the IFN-/ response, or mengo-Zn, which induces
high levels of IFN-/. Furthermore, equal levels of TBK1 activa-
tion were observed in cells infected with both wt mengovirus and
mengo-Zn, indicating that factors upstream of TBK1 are not tar-
geted by mengovirus. These results may seem to contradict earlier
reports that MDA5 and RIG-I are also cleaved in mengovirus-
infected cells (24). However, MDA5 cleavage was observed only in
cells pretreated with poly(I·C) (24), which, as mentioned before,
potentiates cells for virus-induced apoptosis and likely results in
caspase-mediated MDA5 cleavage. In agreement with our obser-
vation that MDA5 is not cleaved in mengovirus-infected cells,
MDA5 also remained intact during EMCV infection without
poly(I·C) pretreatment in an independent study (43). Two reports
have shown that RIG-I, which is dispensable for EMCV RNA rec-
ognition (16), is targeted by EMCV. Barral et al. reported that
RIG-I is cleaved in EMCV-infected cells and implicated 3Cpro as
the responsible proteinase since the cleavage product (of approx-
imately 70 kDa) was similar to the cleavage product released by
3Cpro of PV (26). Another study showed a gradual decrease of
RIG-I during EMCV infection which could be prevented by a
caspase inhibitor, indicating that this is caspase-mediated degra-
dation of RIG-I (43). These authors also demonstrated that re-
combinant EMCV 3Cpro can cleave RIG-I in vitro, resulting in a
putative cleavage product of approximately 50 kDa. However, this
RIG-I fragment was not observed during a normal EMCV infec-
tion (43), suggesting that it may be an artifact of in vitro study,
similar to the MDA5 cleavage that we observed with CVB3 3Cpro
in our own in vitro cleavage experiments.
The exact mechanism that EMCV uses to suppress the IFN-
/ response remains to be clarified. As indicated above, this
blockade likely lies between TBK1 activation and IRF3 phosphor-
ylation. It is known that TBK1 must form a complex with other
kinases, such as the noncanonical IB kinase IKK-epsilon, in or-
der to phosphorylate its substrate, IRF3 (44–46). The assembly of
a functional TBK1 complex requires not only phosphorylation of
TBK1 at serine 172 but also other posttranslational modifications
of IKK-epsilon and the assistance of scaffold proteins, such as
NAP1 and SINTBAD (47). It is possible that mengovirus inter-
feres with the correct assembly of the TBK1 complex to terminate
the signal transduction. Alternatively, IFN-/ shutdown may be
a secondary effect of the so-called nuclear-cytoplasmic trafficking
disorder that is induced by mengovirus leader protein (48). This
causes an unregulated cargo transport between the nucleus and
cytoplasm and possibly interferes with IRF3 activation, since this
transcription factor must shuttle between these two compart-
ments. Intriguingly, the same mutations in the leader protein (e.g.,
those in the Zn finger domain) simultaneously inactivate its activ-
ities in both IFN-/ suppression (16, 22, 34) and the induction of
the nuclear-cytoplasmic trafficking disorder (48), suggesting that
there may be a link between these two phenomena. Future re-
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search is called upon to investigate the exact mechanism of IFN
antagonization by mengovirus.
In short, our data show that several enteroviruses target
MDA5, MAVS, and RIG-I in infected cells and that all do so via the
same mechanisms (i.e., 2Apro targeting MDA5 and MAVS and
3Cpro targeting RIG-I). These cleavage events likely account for
the lack of an IFN-/ response in enterovirus-infected cells. Our
data that TBK1 phosphorylations and, thus, activation are inhib-
ited in CVB3-infected cells indicate that the pathway is shut down
upstream of TBK1. The fact that the RLR pathway is targeted at
multiple steps during infection makes it technically challenging to
demonstrate the biological consequence of these cleavage events.
One would have to simultaneously reconstitute a minimum of
three factors, MDA5, MAVS, and RIG-I, to, it is hoped, study the
effect of an intact RLR signaling pathway on virus replication.
Additionally, enteroviruses may also employ additional mecha-
nisms to ensure effective IFN-/ suppression. For instance, en-
terovirus 2Apro is also known to cause nuclear-cytoplasmic traf-
ficking disorder (49), possibly interfering with IRF3 activation,
and, thereby, further ensure a total shut off of the IFN-/ re-
sponse in infected cells. Although a clear contribution of these
phenomena to IFN-/ inhibition remains to be established, this
study provides important new insights into the potential roles of
enterovirus proteinases in suppressing the RLR-mediated antivi-
ral pathway.
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